Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases.

Chapman TM, Plosker GL, Figgitt DP.

BioDrugs. 2007;21(1):61-3. Review.

PMID:
17263590
2.

VSL#3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases.

Chapman TM, Plosker GL, Figgitt DP.

Drugs. 2006;66(10):1371-87. Review.

PMID:
16903771
3.

Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2005;23(9):945-64. Review.

PMID:
16153136
4.

Acamprosate: a review of its use in the maintenance of abstinence in patients with alcohol dependence.

Scott LJ, Figgitt DP, Keam SJ, Waugh J.

CNS Drugs. 2005;19(5):445-64. Review.

PMID:
15907154
5.

Pregabalin: as adjunctive treatment of partial seizures.

Warner G, Figgitt DP.

CNS Drugs. 2005;19(3):265-72; discussion 273-4. Review.

PMID:
15740180
6.

Oxaliplatin: in operable colorectal cancer.

Keam SJ, Dunn CJ, Figgitt DP.

Drugs. 2005;65(1):89-96; discussion 97-8. Review.

PMID:
15610052
7.

Brivudin (bromovinyl deoxyuridine).

Keam SJ, Chapman TM, Figgitt DP.

Drugs. 2004;64(18):2091-7; discussion 2098-9. Review.

PMID:
15341504
8.

Extended-release metformin hydrochloride. Single-composition osmotic tablet formulation.

Wagstaff AJ, Figgitt DP.

Treat Endocrinol. 2004;3(5):327-32. Review.

PMID:
15330682
9.

Zoledronic acid: a review of its use in patients with advanced cancer.

Perry CM, Figgitt DP.

Drugs. 2004;64(11):1197-211. Review.

PMID:
15161327
10.

Micafungin.

Jarvis B, Figgitt DP, Scott LJ.

Drugs. 2004;64(9):969-82; discussion 983-4. Review.

PMID:
15101786
11.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
12.

Mitoxantrone: a review of its use in multiple sclerosis.

Scott LJ, Figgitt DP.

CNS Drugs. 2004;18(6):379-96. Review.

PMID:
15089110
13.

Intravenous esomeprazole.

Keating GM, Figgitt DP.

Drugs. 2004;64(8):875-82; discussion 883.

PMID:
15059043
14.

Rosuvastatin: a review of its use in the management of dyslipidemia.

Scott LJ, Curran MP, Figgitt DP.

Am J Cardiovasc Drugs. 2004;4(2):117-38. Review. Erratum in: Am J Cardiovasc Drugs. 2005;5(2):130.

PMID:
15049723
15.

Combined hepatitis A and B vaccines: a review of their immunogenicity and tolerability.

Murdoch DL, Goa K, Figgitt DP.

Drugs. 2003;63(23):2625-49. Review.

PMID:
14636084
16.

Oral fludarabine.

Plosker GL, Figgitt DP.

Drugs. 2003;63(21):2317-23. Review.

PMID:
14524733
17.
18.

Tipranavir.

Plosker GL, Figgitt DP.

Drugs. 2003;63(15):1611-8. Review.

PMID:
12887268
19.

Memantine.

Jarvis B, Figgitt DP.

Drugs Aging. 2003;20(6):465-76; discussion 477-8. Review.

PMID:
12710865
20.

Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.

Plosker GL, Figgitt DP.

Drugs. 2003;63(8):803-43. Review.

PMID:
12662126
21.

Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.

Jarvis B, Figgitt DP.

Am J Clin Dermatol. 2003;4(3):203-13. Review.

PMID:
12627996
22.

Combined two-dose hepatitis A and B vaccine (AmBirix).

Jarvis B, Figgitt DP.

Drugs. 2003;63(2):207-13; discussion 214-5.

PMID:
12515566
23.

Bicalutamide: in early-stage prostate cancer.

Carswell CI, Figgitt DP.

Drugs. 2002;62(17):2471-79; discussion 2480-1. Review.

PMID:
12421104
24.

Levofloxacin: an updated review of its use in the treatment of bacterial infections.

Hurst M, Lamb HM, Scott LJ, Figgitt DP.

Drugs. 2002;62(14):2127-67. Review.

PMID:
12269858
25.

Dexmethylphenidate.

Keating GM, Figgitt DP.

Drugs. 2002;62(13):1899-904; discussion 1905-8. Review.

PMID:
12215063
26.

Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.

Bhana N, Ormrod D, Perry CM, Figgitt DP.

Paediatr Drugs. 2002;4(8):515-53. Review.

PMID:
12126455
27.

Spotlight on almotriptan in migraine.

Keam SJ, Goa KL, Figgitt DP.

CNS Drugs. 2002;16(7):501-7. Review.

PMID:
12056924
28.

Vardenafil.

Ormrod D, Easthope SE, Figgitt DP.

Drugs Aging. 2002;19(3):217-27; discussion 228-9. Review. Erratum in: Drugs Aging 2002;19(11):886. Drugs Aging. 2003;20(2):140..

PMID:
12027779
29.

ET-743.

Cvetkovic RS, Figgitt DP, Plosker GL.

Drugs. 2002;62(8):1185-92; discussion 1193-4. Review. Erratum in: Drugs 2002;62(11):1634.

PMID:
12010079
30.

Ceftriaxone: an update of its use in the management of community-acquired and nosocomial infections.

Lamb HM, Ormrod D, Scott LJ, Figgitt DP.

Drugs. 2002;62(7):1041-89. Review.

PMID:
11985490
31.
32.

Spotlight on fluvoxamine in anxiety disorders in children and adolescents.

Cheer SM, Figgitt DP.

CNS Drugs. 2002;16(2):139-44. Review.

PMID:
11825104
33.

Almotriptan: a review of its use in migraine.

Keam SJ, Goa KL, Figgitt DP.

Drugs. 2002;62(2):387-414. Review.

PMID:
11817980
34.

Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

Cheer SM, Figgitt DP.

Paediatr Drugs. 2001;3(10):763-81. Review. Erratum in: Paediatr Drugs 2001;3(11):801.

PMID:
11706925
35.

Denileukin diftitox.

Figgitt DP, Lamb HM, Goa KL.

Am J Clin Dermatol. 2000 Jan-Feb;1(1):67-72; discussion 73. Review.

PMID:
11702307
36.
37.

Telithromycin.

Balfour JA, Figgitt DP.

Drugs. 2001;61(6):815-29; discussion 830-1.

PMID:
11398913
38.

Levosimendan.

Figgitt DP, Gillies PS, Goa KL.

Drugs. 2001;61(5):613-27; discussion 628-9. Review.

PMID:
11368286
39.

Caffeine citrate: a review of its use in apnoea of prematurity.

Comer AM, Perry CM, Figgitt DP.

Paediatr Drugs. 2001;3(1):61-79. Review.

PMID:
11220405
40.
41.

Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Figgitt DP, McClellan KJ.

Drugs. 2000 Oct;60(4):925-54. Review.

PMID:
11085201
42.

Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.

Figgitt DP, Plosker GL.

Drugs. 2000 Aug;60(2):481-516. Review.

PMID:
10983742
43.

Docetaxel: an update of its use in advanced breast cancer.

Figgitt DP, Wiseman LR.

Drugs. 2000 Mar;59(3):621-51. Review.

PMID:
10776837
44.

Insulin glargine.

Gillies PS, Figgitt DP, Lamb HM.

Drugs. 2000 Feb;59(2):253-60; discussion 261-2.

PMID:
10730548
45.

Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections.

Lamb HM, Figgitt DP, Faulds D.

Drugs. 1999 Dec;58(6):1061-97. Review.

PMID:
10651391
46.

Structure-activity relationships for the antileishmanial and antitrypanosomal activities of 1'-substituted 9-anilinoacridines.

Gamage SA, Figgitt DP, Wojcik SJ, Ralph RK, Ransijn A, Mauel J, Yardley V, Snowdon D, Croft SL, Denny WA.

J Med Chem. 1997 Aug 1;40(16):2634-42.

PMID:
9258370
47.

Structure-activity relationships of 9-anilinoacridines as inhibitors of human DNA topoisomerase II.

Figgitt DP, Denny WA, Gamage SA, Ralph RK.

Anticancer Drug Des. 1994 Jun;9(3):199-208.

PMID:
8031452
48.

Synthesis and in vitro evaluation of 9-anilino-3,6-diaminoacridines active against a multidrug-resistant strain of the malaria parasite Plasmodium falciparum.

Gamage SA, Tepsiri N, Wilairat P, Wojcik SJ, Figgitt DP, Ralph RK, Denny WA.

J Med Chem. 1994 May 13;37(10):1486-94.

PMID:
8182707
49.

9-Anilinoacridines as potential antileishmanial agents.

Mauël J, Denny W, Gamage S, Ransijn A, Wojcik S, Figgitt D, Ralph R.

Antimicrob Agents Chemother. 1993 May;37(5):991-6.

50.

Structure-activity relationships and modes of action of 9-anilinoacridines against chloroquine-resistant Plasmodium falciparum in vitro.

Chavalitshewinkoon P, Wilairat P, Gamage S, Denny W, Figgitt D, Ralph R.

Antimicrob Agents Chemother. 1993 Mar;37(3):403-6.

Supplemental Content

Loading ...
Support Center